Everolimus/Lanreotide/TemozolomideDrug ineffective: case report

被引：0

|

作者：

机构：

来源：

Reactions Weekly | 2025年 / 2042卷 / 1期

关键词：

D O I：

10.1007/s40278-025-74988-1

中图分类号：

学科分类号：

摘要：

引用

收藏

页码：189 / 189

相关论文

共 50 条

[1] Everolimus/temozolomideDrug related pneumonitis: 3 case reports
Reactions Weekly, 2016, 1588 (1) : 124 - 124
[2] TemozolomideDrug intolerance: case report
Reactions Weekly, 2025, 2041 (1) : 375 - 375
[3] Cabergoline/temozolomideDrug resistance and nausea: case report
Reactions Weekly, 2022, 1908 (1) : 137 - 137
[4] Lanreotide/octreotidePancreatitis (first report with lanreotide): case report
Reactions Weekly, 1997, 635 (1) : 8 - 8
[5] Everolimus/lanreotide/streptozocinHaemoperitoneum secondary to liver metastasis haemorrhage and lack of efficacy: case report
Reactions Weekly, 2021, 1884 (1) : 196 - 196
[6] Bevacizumab/lapatinib/temozolomideDrug resistance: case report
Reactions Weekly, 2018, 1729 (1) : 51 - 51
[7] Everolimus/Lanreotide/SunitinibLack of efficacy
Reactions Weekly, 2024, 2013 (1) : 195 - 195
[8] Everolimus/Lanreotide/TemozolomideLack of efficacy
Reactions Weekly, 2024, 2009 (1) : 254 - 254
[9] TemozolomideDrug toxicity, pancytopenia and aplastic anaemia: case report
Reactions Weekly, 2023, 1981 (1) : 337 - 337
[10] TemozolomideDrug resistentce during therapy for congenital glioblastoma: case report
Reactions Weekly, 2016, 1587 (1) : 257 - 257

← 1 2 3 4 5 →